Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
06/11/201912:00GlobeNewswire Inc.Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance CongressNASDAQ:SMMTSummit Therapeutics Inc
04/11/201912:00GlobeNewswire Inc.Summit Therapeutics Recognises C. difficile Awareness MonthNASDAQ:SMMTSummit Therapeutics Inc
16/10/201912:00GlobeNewswire Inc.Summit Therapeutics to Present at the 2019 BIO Investor ForumNASDAQ:SMMTSummit Therapeutics Inc
11/10/201912:51Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/10/201912:45Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
11/10/201912:00GlobeNewswire Inc.Half-year reportNASDAQ:SMMTSummit Therapeutics Inc
10/10/201914:30GlobeNewswire Inc.Notice of ResultsNASDAQ:SMMTSummit Therapeutics Inc
07/10/201912:00GlobeNewswire Inc.Summit Therapeutics Reports New Data from Phase 2 Clinical Trial Connecting Ridinilazole’s Microbiome Preservation to Impro...NASDAQ:SMMTSummit Therapeutics Inc
03/10/201912:00GlobeNewswire Inc.Summit Therapeutics Reports Ridinilazole Significantly Improved Short and Longer-Term Quality of Life Measures in Patients wi...NASDAQ:SMMTSummit Therapeutics Inc
01/10/201915:07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:SMMTSummit Therapeutics Inc
25/09/201912:00GlobeNewswire Inc.Summit Therapeutics to Host R&D Day 7 October 2019NASDAQ:SMMTSummit Therapeutics Inc
24/09/201912:00GlobeNewswire Inc.Summit Therapeutics to Present Data from Phase 2 Clinical Trial of Ridinilazole at ID Week 2019NASDAQ:SMMTSummit Therapeutics Inc
18/09/201907:00GlobeNewswire Inc.Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive...NASDAQ:SMMTSummit Therapeutics Inc
05/09/201912:00GlobeNewswire Inc.Summit Presented In Vivo Proof of Concept Data for Targeted Enterobacteriaceae Antibiotics at ASM/ESCMID ConferenceNASDAQ:SMMTSummit Therapeutics Inc
04/09/201912:00GlobeNewswire Inc.Summit Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:SMMTSummit Therapeutics Inc
01/08/201912:00GlobeNewswire Inc.Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
17/07/201912:00GlobeNewswire Inc.Summit Highlighted Potential of SMT-571 to Combat the Rising Global Health Threat of Gonorrhoea at STI & HIV World CongressNASDAQ:SMMTSummit Therapeutics Inc
09/07/201912:00GlobeNewswire Inc.Summit’s DDS-04 Enterobacteriaceae Programme Demonstrates In Vivo Efficacy in Sepsis and PneumoniaNASDAQ:SMMTSummit Therapeutics Inc
01/07/201914:13PR Newswire (US)X-Biotix Therapeutics Joins Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
21/06/201921:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SMMTSummit Therapeutics Inc
21/06/201911:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
20/06/201916:13PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019NASDAQ:SMMTSummit Therapeutics Inc
20/06/201912:00GlobeNewswire Inc.Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019NASDAQ:SMMTSummit Therapeutics Inc
19/06/201921:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
18/06/201921:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
18/06/201912:00GlobeNewswire Inc.Increased BARDA Award and Option ExerciseNASDAQ:SMMTSummit Therapeutics Inc
12/06/201913:20Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:SMMTSummit Therapeutics Inc
12/06/201912:34Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
12/06/201912:00GlobeNewswire Inc.Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 30 April 2019NASDAQ:SMMTSummit Therapeutics Inc
07/06/201914:27PR Newswire (US)Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno...NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT